Stock Insider Trading (from SEC Form 4)
CYTX / Cytori Therapeutics, Inc. insiders include HAWRAN PAUL W (), HAYDEN JEREMY B. (General Counsel & VP of BD), Naughton Gail K (), Thompson Tommy G (), and KESTEN STEVEN (Exec VP and Chief MO), HEDRICK MARC H (President and CEO), RICKEY DAVID (), Lim Kian Thiam, Hawkins Richard J () Girao Tiago (VP & Chief Financial Officer), HARRIS JOHN DAVID (VP and GM Cell Therapy), Swissquote Bank SA, LYONS GARY A (), PostFinance AG, .
Cytori Therapeutics, Inc. insider trades are found here. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Job titles are listed as of the filing and may not be current. Click the link icon to see the full transaction history.
Stop missing out on important events!
|Tran Value||Post Value||Percent
Swissquote Bank SA
HARRIS JOHN DAVID
LYONS GARY A
HAYDEN JEREMY B.
Hawkins Richard J
Naughton Gail K
HEDRICK MARC H
Thompson Tommy G
HAWRAN PAUL W
Lim Kian Thiam
- Open market or private purchase of non-derivative or derivative security
- Open market or private sale of non-derivative or derivative security
- Grant, award, or other acquisition of securities from the company (such as an option)
- Conversion of derivative
- Sale or transfer of securities back to the company
- Payment of exercise price or tax liability using portion of securities received from the company
- Gift of securities by or to the insider
- Equity swaps and similar hedging transactions
- Exercise or conversion of derivative security received from the company (such as an option)
- A transaction voluntarily reported on Form 4
- Other (accompanied by a footnote describing the transaction)
Related News Stories
* CYTORI THERAPEUTICS - ON JAN 25, AS PART OF ONGOING RESTRUCTURING DAVID M. RICKEY AND GAIL K. NAUGHTON, SUBMITTED RESIGNATIONS AS MEMBERS OF BOARD (25-2)
Good afternoon, ladies and gentlemen. Welcome to the Cytori Therapeutics Third Quarter 2017 Earnings Results Call. [Operator Instructions]. (25-2)